Showing 1 - 10 of 13
Persistent link: https://www.econbiz.de/10002471265
Persistent link: https://www.econbiz.de/10011867997
Persistent link: https://www.econbiz.de/10011867999
Persistent link: https://www.econbiz.de/10011868001
Persistent link: https://www.econbiz.de/10011454677
Persistent link: https://www.econbiz.de/10012004860
Background: According to the AMNOG act, the German Federal Joint Committee (G-BA) determines the additional benefit of new medicines as a basis for subsequent price negotiations. Pharmaceutical companies may withdraw their medications from the market at any time during the process. This analysis...
Persistent link: https://www.econbiz.de/10011942830
Persistent link: https://www.econbiz.de/10001698688
Persistent link: https://www.econbiz.de/10001421220
Persistent link: https://www.econbiz.de/10003373796